Exploring binding and effector functions of natural human antibodies using synthetic immunomodulators

ACS Chemical Biology

Volumn 8, Issue 11, 2013, Pages 2404-2411

  Jakobsche, Charles E ^a   Parker, Christopher G ^b   Tao, Ran N ^c   Kolesnikova, Mariya D ^d   Douglass, Eugene F ^c   Spiegel, David A ^c,e  

^a CLARK UNIVERSITY   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c YALE UNIVERSITY   (United States)

^d Axela Inc   (Canada)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 DINITROPHENOL; ANTIGEN; HAPTEN ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; LIGAND; PHOSPHORYLCHOLINE; RHAMNOSE; 2,4-DINITROPHENYLACETIC ACID; ANTIBODY; IMMUNOLOGIC FACTOR; PHENYLACETIC ACID DERIVATIVE; PROTEIN BINDING;

ANIMAL CELL; ANTIGEN BINDING; ARTICLE; CELL ASSAY; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GLIOBLASTOMA; HUMAN; HUMAN CELL; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; SYNTHESIS; TARGET CELL; ANIMAL; BINDING COMPETITION; CELL SURVIVAL; CHEMICAL STRUCTURE; CHEMISTRY; CHO CELL LINE; CRICETULUS; DRUG INDUSTRY; METABOLISM;

ANIMALS; ANTIBODIES; ANTIGENS; BINDING, COMPETITIVE; CELL SURVIVAL; CHO CELLS; CRICETULUS; DRUG INDUSTRY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMANS; IMMUNOLOGIC FACTORS; MOLECULAR STRUCTURE; MOLECULAR WEIGHT; PHENYLACETATES; PHOSPHORYLCHOLINE; PROTEIN BINDING; RHAMNOSE;

EID: 84887978090     PISSN: 15548929     EISSN: 15548937     Source Type: Journal    
DOI: 10.1021/cb4004942     Document Type: Article

References (45)

1. Spiegel, D. A. (2010) Grand challenge commentary: Synthetic immunology to engineer human immunity Nat. Chem. Biol. 6, 871-872
2. McEnaney, P. J., Parker, C. G., Zhang, A. X., and Spiegel, D. A. (2012) Antibody-recruiting molecules: An emerging paradigm for engaging immune function in treating human disease ACS Chem. Biol. 7, 1139-1151
3. Carlson, C. B., Mowery, P., Owen, R. M., Dykhuizen, E. C., and Kiessling, L. L. (2007) Selective tumor cell targeting using low-affinity, multivalent interactions ACS Chem. Biol. 2, 119-127
4. Perdomo, M. F., Levi, M., Sallberg, M., and Vahlne, A. (2008) Neutralization of HIV-1 by redirection of natural antibodies Proc. Natl. Acad. Sci. U.S.A. 105, 12515-12520
5. Jakobsche, C. E., McEnaney, P. J., Zhang, A. X., and Spiegel, D. A. (2012) Reprogramming urokinase into an antibody-recruiting anticancer agent ACS Chem. Biol. 7, 316-321
6. Lu, Y., Klein, P. J., Westrick, E., Xu, L. C., Santhapuram, H. K., Bloomfield, A., Howard, S. J., Vlahov, I. R., Ellis, P. R., Low, P. S., and Leamon, C. P. (2009) Strategy to prevent drug-related hypersensitivity in folate-targeted hapten immunotherapy of cancer AAPS J. 11, 628-638
7. Lu, Y. and Low, P. S. (2002) Folate targeting of haptens to cancer cell surfaces mediates immunotherapy of syngeneic murine tumors Cancer Immunol. Immunother. 51, 153-162
8. Lu, Y., Sega, E., and Low, P. S. (2005) Folate receptor-targeted immunotherapy: induction of humoral and cellular immunity against hapten-decorated cancer cells Int. J. Cancer 116, 710-719
9. Murelli, R. P., Zhang, A. X., Michel, J., Jorgensen, W. L., and Spiegel, D. A. (2009) Chemical control over immune recognition: A class of antibody-recruiting small molecules that target prostate cancer J. Am. Chem. Soc. 131, 17090-17092
10. Parker, C. G., Domaoal, R. A., Anderson, K. S., and Spiegel, D. A. (2009) An antibody-recruiting small molecule that targets HIV gp120 J. Am. Chem. Soc. 131, 16392-16394
11. Oyelaran, O., McShane, L. M., Dodd, L., and Gildersleeve, J. C. (2009) Profiling human serum antibodies with a carbohydrate antigen microarray J. Proteome Res. 8, 4301-4310
12. Chen, W., Gu, L., Zhang, W., Motari, E., Cai, L., Styslinger, T. J., and Wang, P. G. (2011) L-rhamnose antigen: a promising alternative to alpha-gal for cancer immunotherapies ACS Chem. Biol. 6, 185-191
13. Sletten, E. M. and Bertozzi, C. R. (2009) Bioorthogonal chemistry: Fishing for selectivity in a sea of functionality Angew. Chem., Int. Ed. 48, 6974-6998
14. Mineo, J. F., Bordron, A., Quintin-Roue, I., Loisel, S., Ster, K. L., Buhe, V., Lagarde, N., and Berthou, C. (2004) Recombinant humanised anti-HER2/neu antibody (Herceptin) induces cellular death of glioblastomas Br. J. Cancer 91, 1195-1199
15. Fiskesund, R., Stegmayr, B., Hallmans, G., Vikstrom, M., Weinehall, L., de Faire, U., and Frostegard, J. (2010) Low levels of antibodies against phosphorylcholine predict development of stroke in a population-based study from northern Sweden Stroke 41, 607-612
16. Ochs, H. D. and Wedgwood, R. J. (1987) IgG subclass deficiencies Annu. Rev. Med. 38, 325-340
17. Natsume, A., Niwa, R., and Satoh, M. (2009) Improving effector functions of antibodies for cancer treatment: Enhancing ADCC and CDC Drug Des., Dev. Ther. 3, 7-16
18. Sarma, J. V. and Ward, P. A. (2011) The complement system Cell Tissue Res. 343, 227-235
19. Murphy, K., Travers, P., and Walport, M. (2008) Janeway's Immunobiology, 7 th ed., Garland Science, Taylor & Francis Group, NY.
20. Lock, R. J. and Unsworth, D. J. (2003) Immunoglobulins and immunoglobulin subclasses in the elderly Ann. Clin. Biochem. 40, 143-148
21. Siber, G. R., Schur, P. H., Aisenberg, A. C., Weitzman, S. A., and Schiffman, G. (1980) Correlation between serum IgG-2 concentrations and the antibody response to bacterial polysaccharide antigens N. Engl. J. Med. 303, 178-182
22. Yount, W. J., Dorner, M. M., Kunkel, H. G., and Kabat, E. A. (1968) Studies on human antibodies. VI. Selective variations in subgroup composition and genetic markers J. Exp. Med. 127, 633-646
23. Du Clos, T. W. (2002) C-Reactive Protein and the Immune Response Sci. Med. 8, 108-117
24. Volanakis, J. E. (2001) Human C-reactive protein: expression, structure, and function Mol. Immunol. 38, 189-197
25. Friedman, P., Horkko, S., Steinberg, D., Witztum, J. L., and Dennis, E. A. (2002) Correlation of antiphospholipid antibody recognition with the structure of synthetic oxidized phospholipids. Importance of Schiff base formation and aldol condensation J. Biol. Chem. 277, 7010-7020
26. Wang, J.-Q., Chen, X., Zhang, W., Zacharek, S., Chen, Y., and Wang, P. G. (1999) Enhanced inhibition of human anti-Gal antibody binding to mammalian cells by synthetic α-Gal epitope polymers J. Am. Chem. Soc. 121, 8174-8181
27. Ishizaka, K., Ishizaka, T., and Banovitz, J. (1964) Biologic activity of soluble antigen-antibody complexes. IX. Soluble complexes of rabbit antibody with univalent and divalent haptens J. Immunol. 93, 1001-1007
28. Limpert, E., Stahel, W. A., and Abbt, M. (2001) Log-normal distributions across the sciences: Keys and clues BioScience 51, 341-352
29. Yamanishi, S., Iizumi, T., Watanabe, E., Shimizu, M., Kamiya, S., Nagata, K., Kumagai, Y., Fukunaga, Y., and Takahashi, H. (2006) Implications for induction of autoimmunity via activation of B-1 cells by Helicobacter pylori urease Infect. Immun. 74, 248-256
30. Takeshita, H., Taniuchi, I., Kato, J., and Watanabe, T. (1998) Abrogation of autoimmune disease in Lyn-deficient mice by the mutation of the Btk gene Int. Immunol. 10, 435-444
31. Montecino-Rodriguez, E. and Dorshkind, K. (2006) New perspectives in B-1 B cell development and function Trends Immunol. 27, 428-433
32. Martin, F. and Kearney, J. F. (2001) B1 cells: similarities and differences with other B cell subsets Curr. Opin. Immunol. 13, 195-201
33. Martin, F., Oliver, A. M., and Kearney, J. F. (2001) Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens Immunity 14, 617-629
34. Forster, I. and Rajewsky, K. (1987) Expansion and functional activity of Ly-1+ B cells upon transfer of peritoneal cells into allotype-congenic, newborn mice Eur. J. Immunol. 17, 521-528
35. Notkins, A. L. (2004) Polyreactivity of antibody molecules Trends Immunol. 25, 174-179
36. Ortega, E., Kostovetzky, M., and Larralde, C. (1984) Natural DNP-binding immunoglobulins and antibody multispecificity Mol. Immunol. 21, 883-888
37. Chen, Y., Park, Y. B., Patel, E., and Silverman, G. J. (2009) IgM antibodies to apoptosis-associated determinants recruit C1q and enhance dendritic cell phagocytosis of apoptotic cells J. Immunol. 182, 6031-6043
38. Kim, S. J., Gershov, D., Ma, X., Brot, N., and Elkon, K. B. (2002) I-PLA(2) activation during apoptosis promotes the exposure of membrane lysophosphatidylcholine leading to binding by natural immunoglobulin M antibodies and complement activation J. Exp. Med. 196, 655-665
39. Shaw, P. X., Goodyear, C. S., Chang, M. K., Witztum, J. L., and Silverman, G. J. (2003) The autoreactivity of anti-phosphorylcholine antibodies for atherosclerosis-associated neo-antigens and apoptotic cells J. Immunol. 170, 6151-6157
40. Karjalainen, K. and Makela, O. (1976) Concentrations of three hapten-binding immunoglobulins in pooled normal human serum Eur. J. Immunol. 6, 88-93
41. Naicker, K. P., Li, H., Heredia, A., Song, H., and Wang, L. X. (2004) Design and synthesis of alpha Gal-conjugated peptide T20 as novel antiviral agent for HIV-immunotargeting Org. Biomol. Chem. 2, 660-664
42. Bertozzi, C. R. and Bednarski, M. D. (1992) Antibody targeting to bacterial cells using receptor-specific ligands J. Am. Chem. Soc. 114, 2242-2245
43. Krishnamurthy, V. M., Quinton, L. J., Estroff, L. A., Metallo, S. J., Isaacs, J. M., Mizgerd, J. P., and Whitesides, G. M. (2006) Promotion of opsonization by antibodies and phagocytosis of Gram-positive bacteria by a bifunctional polyacrylamide Biomaterials 27, 3663-3674
44. Popkov, M., Gonzalez, B., Sinha, S. C., and Barbas, C. F., 3rd. (2009) Instant immunity through chemically programmable vaccination and covalent self-assembly Proc. Natl. Acad. Sci. U.S.A. 106, 4378-4383
45. Abdel-Motal, U. M., Wigglesworth, K., and Galili, U. (2009) Mechanism for increased immunogenicity of vaccines that form in vivo immune complexes with the natural anti-Gal antibody Vaccine 27, 3072-3082